Arca
Skip to content
Tools
Tools

Osteomyelitis

Drug research and approvals for osteomyelitis: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 18, 2026, 28 studies of osteomyelitis are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, FDA has 0 approved and 2 open orphan designations naming it, and the EU has 1 authorised medicine for it.

  • Recruiting worldwide: 28
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 1

Recruiting now

Newest start dates first, of 28 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 5

Phase 3 7

Phase 2 2

Phase 1 or earlier 12 of 115

How its trials ended

109 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 19 whose ending is known, 32% met their primary endpoint, 5% missed it and 63% stopped early.

  • Ongoing3835%
  • Completed, result not reported3633%
  • Status unknown1615%
  • Met its primary endpoint66%
  • Stopped: other or unclear55%
  • Stopped: enrollment or feasibility33%
  • Stopped: sponsor or business decision22%
  • Missed its primary endpoint11%
  • Stopped: lack of efficacy11%
  • Stopped: funding11%

FDA orphan designations

Approved first, then open designations, newest first
Mar 30, 2015DalbavancinTreatment of acute osteomyelitis in children (0 through 16 years of age)Durata Therapeutics International B.V.Designated
Jan 31, 1991Gentamicin impregnated PMMA beads on surgical wireTreatment of chronic osteomyelitis of post-traumatic, postoperative, or hematogenous origin.Lipha Pharmaceuticals, Inc.Designated

Medicines authorised in the EU

Newest first
AuthorisedMedicineHolderEPAR
Jan 11, 2010ScintimunBesilesomabTelix InnovationsEMA ↗

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.